Seeking AlphaCodex · 实盘不做把握 6/10
北京时间·🕒 发布 20:43:41时区推断·⟳ 抓取 20:43:46·⚡ 决策 07-31 20:48:38 +4m52s·88.1 天前
Contineum Therapeutics披露二季度亏损及现金 runway
这只是常规季度财务摘要，GAAP EPS亏损对临床阶段生物科技公司不构成明确新增交易方向。
📄 原文Seeking Alpha↗ 原文
Contineum Therapeutics GAAP EPS of -$0.40
Earnings News Contineum Therapeutics GAAP EPS of -$0.40 Jul 31, 2026, 8:43 AM ET Contineum Therapeutics, Inc. (CTNM) St…
不做 Contineum Therapeutics（CTNM.US）
常规临床阶段生物科技季报摘要，EPS亏损和现金 runway 未给出可交易的临床、监管、融资或商业化 surprise，不做。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-07-31 · 扩散 low · price-in 风险 medium ↗
关键理由
- 这只是常规季度财务摘要，GAAP EPS亏损对临床阶段生物科技公司不构成明确新增交易方向。
- 现金及证券2.366亿美元、预计支撑至2029年中属于融资 runway 信息，但未披露临床、监管、合作或商业化增量。
主要风险
- 若完整财报或电话会另有临床进展、融资计划或管线延误，需要由新信号重新研判。
原文全文
展开原文 · 603 字
Earnings News
Contineum Therapeutics GAAP EPS of -$0.40
Jul 31, 2026, 8:43 AM ET
Contineum Therapeutics, Inc. (CTNM) Stock
By
:
Jay Mehta
,
SA News Editor
Contineum Therapeutics
press release
(
CTNM
): Q2 GAAP EPS of -$0.40.
Cash, cash equivalents and marketable securities were $236.6 million as of June 30, 2026. Contineum believes its cash resources are sufficient to fund its planned operations through mid-2029.
More on Contineum Therapeutics
Seeking Alpha’s Quant Rating on Contineum Therapeutics
Historical earnings data for Contineum Therapeutics
Financial information for Contineum Therapeutics
Contineum Therapeutics GAAP EPS of -$0.40
Jul 31, 2026, 8:43 AM ET
Contineum Therapeutics, Inc. (CTNM) Stock
By
:
Jay Mehta
,
SA News Editor
Contineum Therapeutics
press release
(
CTNM
): Q2 GAAP EPS of -$0.40.
Cash, cash equivalents and marketable securities were $236.6 million as of June 30, 2026. Contineum believes its cash resources are sufficient to fund its planned operations through mid-2029.
More on Contineum Therapeutics
Seeking Alpha’s Quant Rating on Contineum Therapeutics
Historical earnings data for Contineum Therapeutics
Financial information for Contineum Therapeutics
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。